文献速递皮肤肿瘤

英格兰角质形成细胞癌趋势:2013-22年基底细胞癌与皮肤鳞状细胞癌发病率及非黑色素瘤皮肤癌死亡率

Trends in keratinocyte cancers in England, 2013-22: basal cell carcinoma incidence, cutaneous squamous cell carcinoma incidence and nonmelanoma skin cancer mortality.
PubMed 文献 · Br J Dermatol · 2026-01-01

该研究分析英格兰2013-2022年国家登记数据,采用PPPA法计数肿瘤,计算年龄标化发病率与死亡率。结果显示BCC年龄标化发病率2015年后稳定,cSCC发病率持续上升,NMSC死亡率显著增加且男性增速约为女性两倍。

要点

  • PPPA计数法较首次登记法多识别67%BCC和42%cSCC,影响医疗规划。
  • 2022年BCC和cSCC的EASR分别为295/10万和102/10万人年。
  • NMSC死亡率2013年起显著上升,男性APC 4.4%高于女性2.2%。

核心结论

  • cSCC发病率持续上升且NMSC死亡率增加,需加强预防、早期诊断和及时医疗可及性。

研究设计与样本

  • 基于英格兰国家疾病登记服务2013-2022年所有新诊断角质形成细胞癌的回顾性分析,采用PPPA法计数肿瘤。

主要发现

  • PPPA法较首次登记法多识别67%BCC和42%cSCC。
  • 2022年BCC的EASR为295/10万人年,cSCC为102/10万人年。
  • BCC的EASR初期上升,2015年起稳定(APC -0.2%,95%CI -0.8至0.3)。
  • cSCC的EASR 2013-2015年从79升至89/10万人年(APC 6.1%),2015-2019年从89升至97/10万人年(APC 2.3%)。
  • NMSC的ASMR自2013年显著上升(APC 4.0%,95%CI 2.5-5.7),男性APC 4.4%(95%CI 2.4-7.1),女性APC 2.2%(95%CI 0.3-4.6)。

关键数值与推荐

  • cSCC年龄标化发病率在中青年2015年后趋于平稳,但<60岁和≥80岁人群继续上升。

临床怎么用

  • 应关注cSCC在年轻和老年人群中的发病上升趋势,并加强非黑色素瘤皮肤癌的预防和早期发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), collectively termed keratinocyte cancers (KCs), are the most common cancers in White populations, and their incidence is increasing globally. KCs are substantially under-reported, and high-quality long-term data on patient demographics, incidence and mortality trends remain limited. OBJECTIVES: To describe the characteristics of patients with KCs, and to assess incidence and mortality trends in England between 2013 and 2022. METHODS: We analysed all new KCs diagnosed in England from 2013 to 2022 using data from the National Disease Registration Service. Tumours were counted using per patient per annum (PPPA) methodology, whereby each individual could contribute one BCC and one cSCC per year. European age-standardized incidence rates (EASRs) and age-standardized mortality rates (ASMRs) were calculated using the 2013 European Standard Population, while age-specific incidence rates (ASIRs) were calculated using Office for National Statistics mid-year population estimates for the corresponding age group. Joinpoint regression was used to calculate annual percentage change (APC) and assess trends in EASRs, ASIRs and ASMRs by sex and age per 100 000 person-years (PYs). RESULTS: Compared with the first-all-time registration method, the PPPA approach identified 67% more BCCs and 42% more cSCCs over the study period. In 2022, PPPA EASRs were 295 per 100 000 PYs for BCC and 102 per 100 000 PYs for cSCC. BCC EASRs increased initially before stabilizing from 2015 [APC -0.2%, 95% confidence interval (CI) -0.8 to 0.3]. In contrast, cSCC EASRs increased rapidly from 2013 to 2015 (from 79 to 89 per 100 000 PY; APC 6.1%) and continued to increase between 2015 and 2019 (from 89 to 97 per 100 000 PY; APC 2.3%). The nonmelanoma skin cancer (NMSC) ASMR increased significantly from 2013 (APC 4.0%, 95% CI 2.5-5.7), with rates rising approximately twice as fast in male individuals (APC 4.4%, 95% CI 2.4-7.1) compared with female individuals (APC 2.2, 95% CI 0.3-4.6). For cSCC, ASIRs plateaued in middle age from 2015 onwards but continued to increase in younger (< 60 years) and older (≥ 80 years) individuals. CONCLUSIONS: The findings highlight the importance of accurate tumour counting methods for healthcare planning. The incidence of cSCC continues to rise alongside increasing NMSC mortality, underscoring the need for strengthened prevention strategies, early diagnosis and timely access to quality healthcare. Keratinocytes are the main type of cells in the outer layer of skin. Keratinocyte cancers are the most common types of skin cancer. Keratinocyte cancers include basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). Approximately 1 in 5 people in England will develop at least one of these skin cancers in their lifetime. These cancers mainly affect people with lighter skin. They are mostly caused by exposure to ultraviolet (UV) radiation from the sun. BCC is usually slow growing and rarely life-threatening. cSCC can be more aggressive and spread to other parts of the body. We carried out this study in England using data from the national cancer registry. Our aim was to understand how often these cancers occur. We also wanted to know who is affected and how death rates have changed over time. We investigated all new cases of keratinocyte cancer diagnosed between 2013 and 2022. We found that cases of cSCC have continued to rise over time, including in younger and older age groups. In contrast, we found that the number of BCC cases, when adjusted for an ageing population, increased at first but has remained stable since 2015. We also found that deaths from non-melanoma skin cancer (which includes BCC and cSCC) are increasing, particularly in men. These findings suggest that cSCC is a growing problem in England. This highlights the importance of preventing skin cancer through sun protection, treating pre-cancer and early cancer detection.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Mistry K, Levell NJ, Karponis D, et al. Trends in keratinocyte cancers in England, 2013-22: basal cell carcinoma incidence, cutaneous squamous cell carcinoma incidence and nonmelanoma skin cancer mortality. Br J Dermatol. 2026. PMID: 42508807. doi:10.1093/bjd/ljag315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。